Chad McKenzie, DO
Vascular Surgery · Suffolk, VANPI 1114925500
Payments from drug & device makers
Across 289 payments — averaging $44.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Abbott$918
- Endologix LLC$823
- Johnson & Johnson$717
- Boston Scientific$703
- Bard Peripheral Vascular, Inc.$263
- plus $3K from 35 others
What the payments were for
- Travel & lodging$4,37834%
- Food & beverage$8,62166%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 63 | $6,935 |
| Abbott | 26 | $918 |
| Endologix LLC | 10 | $823 |
| Johnson & Johnson | 47 | $717 |
| Boston Scientific | 39 | $703 |
| Bard Peripheral Vascular, Inc. | 12 | $263 |
| Silk Road Medical, Inc. | 3 | $253 |
| Globus Medical | 3 | $250 |
| Stryker | 4 | $220 |
| Cardiovascular Systems Inc. | 6 | $180 |
| Shockwave Medical, Inc | 4 | $176 |
| Smith+Nephew | 8 | $137 |
| Reflow Medical Inc | 1 | $109 |
| Pfizer | 7 | $103 |
| Sanara Medtech Inc. | 1 | $94 |
| Terumo Medical Corporation | 6 | $89 |
| Acell, Inc. | 3 | $87 |
| Misonix Inc | 4 | $84 |
| Mimedx Group, Inc. | 4 | $79 |
| W. L. Gore & Associates, Inc. | 4 | $71 |
| Philips North America LLC | 1 | $69 |
| Teleflex LLC | 3 | $67 |
| Lemaitre Vascular, Inc. | 4 | $66 |
| Cook Medical LLC | 3 | $61 |
| Novartis | 3 | $59 |
| Cardiva Medical, Inc. | 4 | $57 |
| Atricure, Inc. | 2 | $52 |
| Integra Lifesciences Corporation | 1 | $42 |
| Convatec Inc. | 1 | $38 |
| Polynovo North America LLC | 1 | $27 |
| Organogenesis Inc. | 1 | $21 |
| Angiodynamics, Inc. | 1 | $19 |
| Cardinal Health 200 LLC | 1 | $18 |
| AstraZeneca | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $16 |
| Shape Memory Medical Inc. | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Penumbra, Inc. | 1 | $14 |
| Centinel Spine, LLC | 1 | $13 |
| Getinge USA Sales, LLC | 1 | $13 |
| Elutia, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENDURANT IIS$4,980
- Endurant$308
- Alto Abdominal Stent Graft System$233
- ALIF$220
- ESPRIT$163
- Valiant Captivia$157
- VARIAX$141
- Supera peripheral stent system$131
- ENDOCROSS Device$119
- Torus Stent Graft System$119
- ENROUTE Transcarotid Neuroprotection System$113
- ENROUTE Transcarotid Stent System$113
- ENHANCE Transcarotid Peripheral Access Kit$113
- ENROUTE 0.014 Guidewire$113
- Ovation$108
- AFX2$108
How this compares
$12,998 in reported general payments places this provider in the 60th percentile of 143 vascular surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 162 | $115,898 |
| BrilintaTicagrelor | 27 | $14,113 |
| ClopidogrelClopidogrel Bisulfate | 235 | $2,440 |
| Cilostazol | 84 | $1,420 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 64 | $553 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 30 | $289 |
| Gabapentin | 35 | $175 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $135 |
| Duloxetine Hcl | 12 | $60 |
| Levofloxacin | 12 | $44 |
| Prednisone | 11 | $11 |
| Famotidine | 11 | $5 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $103 | $115,898162 claims |
| AstraZenecaBrilinta | $17 | $14,11327 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 143 vascular surgery providers in Virginia.
Other vascular surgery in Suffolk
- David DexterNorfolk$2.3M
- Jean PannetonVirginia Beach$1.8M
- John DeitrickRichmond$684K
- Rasesh ShahChesapeake$575K
- Samuel SteermanVirginia Beach$330K
- Joshua AdamsRoanoke$316K
- Joseph BabrowiczFairfax$214K
- Anthony ComerotaFalls Church$175K
- Animesh RathoreNorfolk$129K
- John KernCharlottesville$128K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.